Retinoids - Which dermatological indications will benefit in the near future?

Skin Pharmacology and Applied Skin Physiology

Volumn 14, Issue 5, 2001, Pages 303-315

  Zouboulis, Christos C ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Clinical indications; Retinoids

Indexed keywords

ADAPALENE; ALITRETINOIN; ALPHA INTERFERON; BEXAROTENE; DIFFERINE; DIMER; ETRETIN; ETRETINATE; FENRETINIDE; ISOTRETINOIN; LIOTHYRONINE RECEPTOR; MEQUINOL PLUS RETINOIC ACID; MOTRETINIDE; RETINAL; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; RETINOL; RETINOL ACTIF PUR; RETINOL CONCENTRE PUR; TAZAROTENE; TRANSCRIPTION FACTOR AP 1; VITAMIN D RECEPTOR; YSTHEAL;

ACNE; CANCER PREVENTION; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; DISSOCIATION; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DYSKERATOSIS; FOLLICULITIS; HUMAN; KAPOSI SARCOMA; LENTIGINOSIS; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; LIGAND BINDING; MOLECULE; PITYRIASIS; PRECANCER; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PSORIASIS; RETINOL DEFICIENCY; REVIEW; ROSACEA; SEBORRHEA; SIGNAL TRANSDUCTION; T CELL LYMPHOMA;

ANIMALS; HUMANS; RETINOIDS; SKIN DISEASES;

EID: 0035742010     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056361     Document Type: Review

References (90)

1. Retinoids
2. Current use and future potential role of retinoids in dermatology
3. Retinoide
4. Retinoide - Wirksamkeit und verträglichkeit der systemischen therapie
5. The synthetic chemistry of retinoids
6. Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer
7. Oral retinoids in the treatment of seborrhoea and acne
8. Isotretinoin in dermatology
9. Oral retinoids - Efficacy and toxicity in psoriasis
10. Treatment of psoriasis with retinoids: Present status
11. 13-cis-Retinoic acid is an endogenous compound in human serum
12. Are endogenous retinoids involved in the pathogenesis of acne?
13. Systemic retinoids - What's new?
14. Retinoids: Transport, metabolism, and mechanisms of action
15. Retinoic acid receptors and cellular retinoid binding proteins: Complex interplay in retinoid signaling
16. Retinoid signaling by all-trans retinoic acid and all-trans retinoyl-β-D-glucuronide is attenuated by simultaneous exposure of human keratinocytes to retinol
17. Retinoid metabolism in the skin
18. The retinoid receptors
19. Retinoids and psoriasis: Novel issues in retinoid pharmacology and implications for psoriasis treatment
20. Synthetic retinoids: Differential binding to retinoic acid receptors
21. Tazarotene
22. 13-cis Retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors
23. The retinoid signaling pathway: Molecular and genetic analysis
24. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor
25. Therapeutic applications for ligands of retinoid receptors
26. Adapalene - A review of its pharmacological properties and clinical potential in the management of mild to moderate acne
27. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel
28. Bexarotene ligand pharmaceuticals
29. Vitamin D3-retinoids association: Molecular basis and clinical application
30. Cross-coupling of signal transduction pathways: Zink finger meets leucine zipper
31. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation
32. Unique anti-activator protein-1 activity of retinoic acid receptor beta
33. Advances in the development of retinoids as chemopreventive agents
34. Natural retinoids: Metabolism and transport in human epidermal cells
35. Overexpression of cellular retinoic acid-binding protein type II (CRABP-II) and down-regulation of CRABP-I in psoriatic skin
36. Retinoids: Unapproved uses or indications
37. Acitretin therapy is effective for psoriasis associated with human immunodeficiency virus infection
38. Treatment of classic pityriasis rubra pilaris
39. Isotretinoin-PUVA in women with psoriasis
40. The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis
41. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis
42. Topical treatment of ichthyoses and Darier's disease with 13-cis-retinoic acid. A clinical and immunohistochemical study
43. Topical application of tazarotene in the treatment of non-erythrodermic lamellar ichthyosis
44. Tazarotene gel for Darier's disease
45. Effective treatment of localized Darier's disease with adapalene 0.1% gel
46. Roaccutane treatment guidelines: Results of an international survey
47. A multi-centre, single-blind, randomised comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac®) applied once daily and a clindamycin lotion formulation (Dalacin T®) applied twice daily in the topical treatment of acne vulgaris
48. Prospective randomized multicenter clinical trial on the use of interferon-α-2a plus acitretin versus interferon-2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II
49. Treatment of early AIDS-related Kaposi's sarcoma with oral all-trans-retinoic acid: Results of a sequential non-randomized phase II trial
50. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells
51. Inhibitory effects of 9-cis-retinoic acid and pyrrolidinedithiocarbamate on cyclooxygenase (COX)-2 expression and cell growth in human skin squamous carcinoma cells
52. 1 cells treated with retinoic acid
53. Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma
54. High dose etretinate and interferon-alpha - A phase I study in squamous cell carcinomas and transitional cell carcinomas
55. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: A double-blind, placebo-controlled study
56. Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin
57. Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients
58. Etretinate may work where acitretin fails
59. A practical approach to the use of retinoids in aging skin
60. Isotretinoin improves the appearance of photodamaged skin: Results of a 36-week, multicenter, double-blind, placebo-controlled trial
61. Photodamage pilot study: A double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel
62. The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies
63. Biological activities of topical retinaldehyde
64. Oral 13-cisretinoic acid is superior to 9-cisretinoic acid in sebosuppression in human beings
65. Sebum excretion rate in subjects treated with oral all-trans retinoic acid
66. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea
67. Managing actinic keratoses with retinoids
68. Evaluation of the efficacy and safety of 0.05% tretinoin cream in the treatment of plane warts in Arab children
69. Topical tretinoin (retinoic acid) improves early stretch marks
70. The role of retinoids in wound healing
71. Treatment of lichen planus: An evidence-based medicine analysis of efficacy
72. Efficacy of oral low-dose tretinoin (all-trans-retinoic acid) in lichen planus
73. Resolution of generalized granuloma annulare with isotretinoin therapy
74. Eosinophilic pustular folliculitis (Ofuji's disease)
75. Isotretinoin treatment of human immunodeficiency virus-associated eosinophilic folliculitis
76. Comparative study of systemic interferon alfa-2a plus isotretinoin versus isotretinoin in the treatment of recurrent condyloma acuminatum in men
77. Clinical evaluation of topical isotretinoin in the treatment of actinic keratoses
78. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: A double-blind, placebo-controlled study
79. Successful treatment of chronic hand eczema with oral 9-cis-retinoic acid
80. Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease
81. Retinoids in chemoprevention and differentiation therapy
82. Retin-A Micro. Plastic Surgery Educational Foundation DATA Committee. Device and Technique Assessment
83. Isotretinoin: A new formulation
84. Phase I trial of 9-cisretinoic acid in adults with solid tumors
85. A phase I study of LGD1069 in adults with advanced cancer
86. Bioactivities of N-(4-hydroxyphenyl) retinamide and retinoyl beta-glucuronide
87. Effects of topical treatment with fenretinide (4-HPR) and plasma vitamin A levels in patients with actinic keratoses
88. Initial clinical trial of a high-affinity retinoic acid receptor ligand (LGD1550)
89. Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metallo-proteinases and stimulates collagen accumulation in naturally aged human skin
90. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: Absorption, metabolism, excretion and plasma protein binding in various animals and man